1. Search Result
Search Result
Results for "

Didanosine

" in MedChemExpress (MCE) Product Catalog:

5

Inhibitors & Agonists

2

Isotope-Labeled Compounds

1

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-B0249
    Didanosine
    1 Publications Verification

    2',3'-Dideoxyinosine; ddI

    HIV Reverse Transcriptase Infection
    Didanosine (2',3'-Dideoxyinosine; ddI) is a a potent and orally active dideoxynucleoside analogue, and also is a potent nucleoside reverse transcriptase inhibitor. Didanosine shows antiretroviral activity for HIV .
    Didanosine
  • HY-B0249S

    Isotope-Labeled Compounds HIV Reverse Transcriptase Infection
    Didanosine-d2 is the deuterium labeled Didanosine. Didanosine (Videx) is a reverse transcriptase inhibitor with an IC50 of 0.49 μM.
    Didanosine-d2
  • HY-B0249R

    2',3'-Dideoxyinosine (Standard); ddI (Standard)

    Reference Standards HIV Reverse Transcriptase Infection
    Didanosine (Standard) is the analytical standard of Didanosine. This product is intended for research and analytical applications. Didanosine (2',3'-Dideoxyinosine; ddI) is a a potent and orally active dideoxynucleoside analogue, and also is a potent nucleoside reverse transcriptase inhibitor. Didanosine shows antiretroviral activity for HIV .
    Didanosine (Standard)
  • HY-W765997

    2',3'-Dideoxyinosine-13C2,15N; ddI-13C2,15N

    Isotope-Labeled Compounds Reverse Transcriptase HIV Infection
    Didanosine- 13C2, 15N (2',3'-Dideoxyinosine- 13C2, 15N; ddI- 13C2, 15N) is the 13C- and 15N-labeled labeled Didanosine (HY-B0249). Didanosine (2',3'-Dideoxyinosine; ddI) is a a potent and orally active dideoxynucleoside analogue, and also is a potent nucleoside reverse transcriptase inhibitor. Didanosine shows antiretroviral activity for HIV .
    Didanosine-13C2,15N
  • HY-122268

    HIV Infection
    QYL-685 is a Z-methenylcyclopropane nucleoside analog containing 2,6-diaminopurine, which has strong antiviral activity against HIV-1. QYL-685 showed activity against Zidovudine (HY-17413) resistant and Didanosine (HY-B0249) resistant HIV-1 infected clones in vitro. QYL-685 can be developed as a therapeutic drug for HIV-1 infection .
    QYL-685

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: